top of page



Boaz Shenhav
CEO
Bio ReFine has developed a unique endovascular annuloplasty remodeling system, without an implant, for the repair of the mitral and tricuspid heart valves.
The innovative technology will offer treatment to a huge population that is not currently treated due to the high risk of open surgery.
The implantless solution offers multiple advantages: significantly easier regulation, it uses a standard endovascular approach, the procedure is safe, implant-free, repeatable and does not prevent ancillary procedures.

PORTFOLIO
Product

DEVICES


PHARMA & BIOTECH


PHARMA & BIOTECH

bottom of page